For the current quarter ending in March, Boston Scientific expects its per-share earnings to range from 66 cents to 68 cents. The company expects full-year earnings in the range of $2.80 to $2.87 per ...

CEO Michael Mahoney highlighted the company’s exceptional performance in 2024, with operational sales growth of 23% in Q4 and 18.5% for the full year. Organic sales grew 20% in Q4, exceeding guidance.

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

Sen. Ted Cruz released a database of over 3,400 National Science Foundation grants awarded towards what he deemed ...

A panel of 14 medical experts say that no babies were murdered in Lucy Letby's care. They have come together to publish what ...

BOSTON (AP) — Kyrone Alexander scored 21 points to lead Boston University, including the game-winning jump shot with six seconds remaining in double, and the Terriers beat Colgate 93-91 on Saturday.

So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...

Feb 5 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Epipelagic Ventures is focused on education and technology investments in the Boston area. Jane Chen, a Harvard University graduate and former investment banker and hedge fund analyst on Wall ...